Nuvalent Stock Performance
| NUVL Stock | USD 102.97 1.75 1.73% |
On a scale of 0 to 100, Nuvalent holds a performance score of 13. The company secures a Beta (Market Risk) of 1.66, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nuvalent will likely underperform. Please check Nuvalent's downside variance, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether Nuvalent's current price movements will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Nuvalent are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Nuvalent disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.73 | Five Day Return 12.03 | Year To Date Return 28.73 | Ten Year Return 449.17 | All Time Return 449.17 |
1 | Disposition of 109 shares by Darlene Noci of Nuvalent at 75.63 subject to Rule 16b-3 | 08/25/2025 |
2 | Disposition of 2007 shares by Henry Pelish of Nuvalent at 0.87 subject to Rule 16b-3 | 08/29/2025 |
3 | Disposition of 20000 shares by Balcom Alexandra of Nuvalent at 6.89 subject to Rule 16b-3 | 09/30/2025 |
4 | Alexandra Balcom Sells 7,588 Shares of Nuvalent Stock | 10/03/2025 |
5 | Nuvalents SWOT analysis oncology innovators stock faces pivotal year By Investing.com - Investing.com South Africa | 10/08/2025 |
6 | Disposition of 825 shares by Henry Pelish of Nuvalent at 29.33 subject to Rule 16b-3 | 10/14/2025 |
7 | Disposition of 4900 shares by Miller Deborah Ann of Nuvalent at 92.5 subject to Rule 16b-3 | 10/16/2025 |
8 | Nuvalent CLO Miller sells 474k in NUVL stock - Investing.com | 10/22/2025 |
9 | Is There An Opportunity With Nuvalent, Inc.s 33 percent Undervaluation | 10/29/2025 |
| Begin Period Cash Flow | 335.4 M | |
| Total Cashflows From Investing Activities | -573.5 M |
Nuvalent Relative Risk vs. Return Landscape
If you would invest 7,776 in Nuvalent on August 1, 2025 and sell it today you would earn a total of 2,521 from holding Nuvalent or generate 32.42% return on investment over 90 days. Nuvalent is currently generating 0.485% in daily expected returns and assumes 2.7834% risk (volatility on return distribution) over the 90 days horizon. In different words, 24% of stocks are less volatile than Nuvalent, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nuvalent Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nuvalent's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nuvalent, and traders can use it to determine the average amount a Nuvalent's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1743
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NUVL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.78 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.49 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Nuvalent is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nuvalent by adding it to a well-diversified portfolio.
Nuvalent Fundamentals Growth
Nuvalent Stock prices reflect investors' perceptions of the future prospects and financial health of Nuvalent, and Nuvalent fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nuvalent Stock performance.
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 5.04 B | ||||
| Shares Outstanding | 66.67 M | ||||
| Price To Earning | (0.06) X | ||||
| Price To Book | 6.43 X | ||||
| EBITDA | (280.37 M) | ||||
| Net Income | (260.76 M) | ||||
| Cash And Equivalents | 256.96 M | ||||
| Cash Per Share | 5.31 X | ||||
| Total Debt | 71.96 M | ||||
| Debt To Equity | 2.81 % | ||||
| Current Ratio | 25.79 X | ||||
| Book Value Per Share | 13.05 X | ||||
| Cash Flow From Operations | (185.06 M) | ||||
| Earnings Per Share | (4.92) X | ||||
| Market Capitalization | 7.3 B | ||||
| Total Asset | 1.14 B | ||||
| Retained Earnings | (547.05 M) | ||||
| Working Capital | 1.08 B | ||||
| Current Liabilities | 5.46 M | ||||
About Nuvalent Performance
By examining Nuvalent's fundamental ratios, stakeholders can obtain critical insights into Nuvalent's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Nuvalent is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.23) | (0.24) | |
| Return On Capital Employed | (0.26) | (0.24) | |
| Return On Assets | (0.23) | (0.24) | |
| Return On Equity | (0.24) | (0.26) |
Things to note about Nuvalent performance evaluation
Checking the ongoing alerts about Nuvalent for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nuvalent help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Net Loss for the year was (260.76 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Nuvalent currently holds about 256.96 M in cash with (185.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.31. | |
| Nuvalent has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from thefly.com: Johnson Johnson in talks to buy Protagonist Therapeutics, WSJ reports JNJPTGX |
- Analyzing Nuvalent's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nuvalent's stock is overvalued or undervalued compared to its peers.
- Examining Nuvalent's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nuvalent's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nuvalent's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nuvalent's stock. These opinions can provide insight into Nuvalent's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.